Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Stem Cells International|June 2, 2016
Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem CellsAde Kallas-Kivi, Annika Trei, Toivo MaimetsThrombosis Research|March 23, 2007
von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient miceAde Kallas, Sulev Kuuse, Toivo Maimets, et al.Stem Cells International|April 8, 2014
SOX2 Is Regulated Differently from NANOG and OCT4 in Human Embryonic Stem Cells during Early Differentiation Initiated with Sodium ButyrateAde Kallas, Martin Pook, Annika Trei, et al.International Journal of Cell Biology|December 6, 2014
Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 CellsAde Kallas, Martin Pook, Annika Trei, et al.Plos One|May 12, 2011
Nocodazole treatment decreases expression of pluripotency markers Nanog and Oct4 in human embryonic stem cellsAde Kallas, Martin Pook, Martti Maimets, et al.Plos One|September 18, 2015
Changes in Laminin Expression Pattern during Early Differentiation of Human Embryonic Stem CellsMartin Pook, Indrek Teino, Ade Kallas, et al.Thrombosis Research|February 5, 2003
Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factorAde Kallas, Margus Pooga, Abdellah Benhida, et al.Biology Open|November 3, 2018
The role of integrin β1 in the heterogeneity of human embryonic stem cells cultureAde Kallas-Kivi, Annika Trei, Artjom Stepanjuk, et al.Pageof 1